Tumor necrosis factor alpha and its receptors in behaviour and neurobiology of adult mice, in the absence of an immune challenge

Behavioural Brain Research

Volumn 290, Issue , 2015, Pages 51-60

  Camara, Marie Lou ^a,b,c   Corrigan, Frances ^a   Jaehne, Emily J ^a   Jawahar, M Catharine ^a   Anscomb, Helen ^b   Baune, Bernhard T ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cognition; Depression; Neurotrophins; TNF ; TNF receptor

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; NERVE GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BARNES MAZE TEST; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; CONTROLLED STUDY; ELEVATED ZERO MAZE TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED SWIM TEST; HIPPOCAMPUS; IMMOBILITY; IMMUNE SYSTEM; LOCOMOTION; MALE; MOUSE; MOUSE STRAIN; NEUROBIOLOGY; NONHUMAN; OPEN FIELD TEST; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; AGE; ANIMAL; C57BL MOUSE; DEPRESSION; EXPLORATORY BEHAVIOR; HUMAN; KNOCKOUT MOUSE; MEMORY; METABOLISM; PHYSIOLOGY;

AGE FACTORS; ANIMALS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; HUMANS; MALE; MEMORY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE GROWTH FACTORS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84929176210     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2015.04.040     Document Type: Article

References (51)

1. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010, 67:446-457.
2. Medeiros R., Prediger R.D., Passos G.F., Pandolfo P., Duarte F.S., Franco J.L., et al. Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein. J Neurosci 2007, 27:5394-5404.
3. Albensi B.C., Mattson M.P. Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity. Synapse 2000, 35:151-159.
4. Golan H., Levav T., Mendelsohn A., Huleihel M. Involvement of tumor necrosis factor alpha in hippocampal development and function. Cereb Cortex 2004, 14:97-105.
5. Tartaglia L.A., Ayres T.M., Wong G.H., Goeddel D.V. A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993, 74:845-853.
6. Rothe M., Pan M.G., Henzel W.J., Ayres T.M., Goeddel D.V. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 1995, 83:1243-1252.
7. Nadeau S., Rivest S. Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear factor kappa B activity in the brain during endotoxemia. J Neurosci 2000, 20:3456-3468.
8. Camara M.L., Corrigan F., Jaehne E.J., Jawahar M.C., Anscomb H., Koerner H., et al. TNF-alpha and its receptors modulate complex behaviours and neurotrophins in transgenic mice. Psychoneuroendocrinology 2013, 38:3102-3114.
9. Simen B.B., Duman C.H., Simen A.A., Duman R.S. TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry 2006, 59:775-785.
10. Baune B.T., Wiede F., Braun A., Golledge J., Arolt V., Koerner H. Cognitive dysfunction in mice deficient for TNF- and its receptors. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1056-1064.
11. McAfoose J., Koerner H., Baune B.T. The effects of TNF deficiency on age-related cognitive performance. Psychoneuroendocrinology 2009, 34:615-619.
12. Peng S., Wuu J., Mufson E.J., Fahnestock M. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem 2005, 93:1412-1421.
13. Castren E., Voikar V., Rantamaki T. Role of neurotrophic factors in depression. Curr Opin Pharmacol 2007, 7:18-21.
14. Korner H., Cook M., Riminton D.S., Lemckert F.A., Hoek R.M., Ledermann B., et al. Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur J Immunol 1997, 27:2600-2609.
15. Peschon J.J., Torrance D.S., Stocking K.L., Glaccum M.B., Otten C., Willis C.R., et al. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol 1998, 160:943-952.
16. Erickson S.L., de Sauvage F.J., Kikly K., Carver-Moore K., Pitts-Meek S., Gillett N., et al. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 1994, 372:560-563.
17. Jaehne E.J., Baune B.T. Effects of chemokine receptor signalling on cognition-like, emotion-like and sociability behaviours of CCR6 and CCR7 knockout mice. Behav Brain Res 2014, 261:31-39.
18. Cryns K., Shamir A., Shapiro J., Daneels G., Goris I., Van Craenendonck H., et al. Lack of lithium-like behavioral and molecular effects in IMPA2 knockout mice. Neuropsychopharmacology 2007, 32:881-891.
19. Petit-Demouliere B., Chenu F., Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl) 2005, 177:245-255.
20. Moy S.S., Nadler J.J., Perez A., Barbaro R.P., Johns J.M., Magnuson T.R., et al. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 2004, 3:287-302.
21. Davidson R.J. Anxiety and affective style: role of prefrontal cortex and amygdala. Biol Psychiatry 2002, 51:68-80.
22. Gilmore J.H., Jarskog L.F., Vadlamudi S. Maternal infection regulates BDNF and NGF expression in fetal and neonatal brain and maternal-fetal unit of the rat. J Neuroimmunol 2003, 138:49-55.
23. Sei H., Saitoh D., Yamamoto K., Morita K., Morita Y. Differential effect of short-term REM sleep deprivation on NGF and BDNF protein levels in the rat brain. Brain Res 2000, 877:387-390.
24. Sweatt J.D. Hippocampal function in cognition. Psychopharmacology (Berl) 2004, 174:99-110.
25. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
26. Beattie E.C., Stellwagen D., Morishita W., Bresnahan J.C., Ha B.K., Von Zastrow M., et al. Control of synaptic strength by glial TNFalpha. Science 2002, 295:2282-2285.
27. Stellwagen D., Beattie E.C., Seo J.Y., Malenka R.C. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 2005, 25:3219-3228.
28. Cheng B., Christakos S., Mattson M.P. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 1994, 12:139-153.
29. Baune B.T., Camara M-l Eyre H., Jawahar C., Anscomb H., Koerner H. Tumour necrosis factor alpha mediated mechanisms of cognitive dysfunction. Trans Neurosci 2012, 3:263-277.
30. McAfoose J., Baune B.T. Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev 2009, 33:355-366.
31. Naude P.J., Dobos N., van der Meer D., Mulder C., Pawironadi K.G., den Boer J.A., et al. Analysis of cognition, motor performance and anxiety in young and aged tumor necrosis factor alpha receptor 1 and 2 deficient mice. Behav Brain Res 2014, 258:43-51.
32. Krugel U., Fischer J., Radicke S., Sack U., Himmerich H. Antidepressant effects of TNF-alpha blockade in an animal model of depression. J Psychiatr Res 2013, 47:611-616.
33. Diniz B.S., Teixeira A.L., Ojopi E.B., Talib L.L., Mendonca V.A., Gattaz W.F., et al. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease. J Alzheimers Dis 2010, 22:1305-1311.
34. Tulner D.M., Smith O.R., Schins A., de Jonge P., Quere M., Delanghe J.R., et al. Antidepressive effect of mirtazapine in post-myocardial infarction depression is associated with soluble TNF-R1 increase: data from the MIND-IT. Neuropsychobiology 2011, 63:169-176.
35. Churchill L., Taishi P., Wang M., Brandt J., Cearley C., Rehman A., et al. Brain distribution of cytokine mRNA induced by systemic administration of interleukin-1beta or tumor necrosis factor alpha. Brain Res 2006, 1120:64-73.
36. Zhu B., Wang Z.G., Ding J., Liu N., Wang D.M., Ding L.C., et al. Chronic lipopolysaccharide exposure induces cognitive dysfunction without affecting BDNF expression in the rat hippocampus. Exp Ther Med 2014, 7:750-754.
37. Saha R.N., Liu X., Pahan K. Up-regulation of BDNF in astrocytes by TNF-alpha: a case for the neuroprotective role of cytokine. J Neuroimmune Pharmacol 2006, 1:212-222.
38. Kelly A., Maguire C., Lynch M.A. Deficits in nerve growth factor release and tyrosine receptor kinase phosphorylation are associated with age-related impairment in long-term potentiation in the dentate gyrus. Neuroscience 2000, 95:359-365.
39. Takei Y., Laskey R. Interpreting crosstalk between TNF-alpha and NGF: potential implications for disease. Trends Mol Med 2008, 14:381-388.
40. Capsoni S., Ugolini G., Comparini A., Ruberti F., Berardi N., Cattaneo A. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc Natl Acad Sci USA 2000, 97:6826-6831.
41. Ruberti F., Capsoni S., Comparini A., Di Daniel E., Franzot J., Gonfloni S., et al. Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy. J Neurosci 2000, 20:2589-2601.
42. Minter R.M., Rectenwald J.E., Fukuzuka K., Tannahill C.L., La Face D., Tsai V., et al. TNF-alpha receptor signaling and IL-10 gene therapy regulate the innate and humoral immune responses to recombinant adenovirus in the lung. J Immunol 2000, 164:443-451.
43. Ralph P., Nakoinz I., Sampson-Johannes A., Fong S., Lowe D., Min H.Y., et al. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol 1992, 148:808-814.
44. Saperstein S., Chen L., Oakes D., Pryhuber G., Finkelstein J. IL-1beta augments TNF-alpha-mediated inflammatory responses from lung epithelial cells. J Interferon Cytokine Res 2009, 29:273-284.
45. Winzen R., Wallach D., Kemper O., Resch K., Holtmann H. Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1. J Immunol 1993, 150:4346-4353.
46. Hultner L., Kolsch S., Stassen M., Kaspers U., Kremer J.P., Mailhammer R., et al. In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9. J Immunol 2000, 164:5556-5563.
47. Vila-del Sol V., Punzon C., Fresno M. IFN-gamma-induced TNF-alpha expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages. J Immunol 2008, 181:4461-4470.
48. Celada A., Maki R.A. IFN-gamma induces the expression of the genes for MHC class II I-A beta and tumor necrosis factor through a protein kinase C-independent pathway. J Immunol 1991, 146:114-120.
49. Mansfield A.S., Nevala W.K., Dronca R.S., Leontovich A.A., Shuster L., Markovic S.N. Normal ageing is associated with an increase in Th2 cells, MCP-1 (CCL1) and RANTES (CCL5), with differences in sCD40L and PDGF-AA between sexes. Clin Exp Immunol 2012, 170:186-193.
50. Sparkman N.L., Johnson R.W. Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress. Neuroimmunomodulation 2008, 15:323-330.
51. Cribbs D.H., Berchtold N.C., Perreau V., Coleman P.D., Rogers J., Tenner A.J., et al. Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J Neuroinflammation 2012, 9:179.